These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 761038)

  • 21. [Medico-social importance and therapeutic measures in vascular diseases. Opinion of Prof. G. Guagliano].
    Guagliano G
    Minerva Cardioangiol; 1974 May; 22(5):388-9. PubMed ID: 4465748
    [No Abstract]   [Full Text] [Related]  

  • 22. [Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Oct; 23(10):607-21. PubMed ID: 1232566
    [No Abstract]   [Full Text] [Related]  

  • 23. [Trial treatment of atherosclerosis--derived ischemia of the lower extremities with dusodril (author's transl)].
    Stadnik J; Cieślik R; Jarochowski M; Macyszyn R
    Przegl Lek; 1977; 34(2):309-11. PubMed ID: 866718
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dusodril in trials of ear buzzing treatment (author's transl)].
    Gierek T; Wróbel M
    Otolaryngol Pol; 1981; 35(1):13-6. PubMed ID: 7019818
    [No Abstract]   [Full Text] [Related]  

  • 25. [Venous obstruction plethysmographic studies on the "borrowing-lending phenomenon" during use of pentoxifyllin and naftidrofuryl].
    Heidrich H; Schartl M
    Verh Dtsch Ges Inn Med; 1978; (84):1403-6. PubMed ID: 741978
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
    Becker HM; Elert O; Häring R; Maurer PC; Raithel D; Sperling M; Stockmann U; Storz LW; Hirche H
    Med Welt; 1979 Oct; 30(43):1602-6. PubMed ID: 514039
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice.
    Brodie NH
    Practitioner; 1977 Feb; 218(1304):274-9. PubMed ID: 320593
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of naftidrofuryl on pathological EEG topography.
    Foit A; Bischoff W; Breinlinger U; Kornhuber HH
    Vasa Suppl; 1988; 24():56-9. PubMed ID: 3212605
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of naftidrofuryl through prolonged intra-arterial perfusion in obliterating arteriopathies of the lower limbs].
    Cospite M; Ferrara F; Ballo M; Lo Presti T; Raimondi F; Meli F; Milio G
    Minerva Cardioangiol; 1980 May; 28(5):359-66. PubMed ID: 7207826
    [No Abstract]   [Full Text] [Related]  

  • 30. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
    Valentin A; Karnik R; Stöllberger C; Slany J
    Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
    Kriessmann A; Neiss A
    Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic possibilities in patients with senile dementia.
    Castleden CM
    J R Coll Physicians Lond; 1984 Jan; 18(1):28-31. PubMed ID: 6323706
    [No Abstract]   [Full Text] [Related]  

  • 33. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
    Horsch S
    Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
    Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
    G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
    [No Abstract]   [Full Text] [Related]  

  • 35. [Can the progression of arteriosclerosis be influenced pharmaco- logically?].
    Rudofsky G; Hirche H; Drück A; Altenhoff B
    Vasa Suppl; 1988; 24():67-75. PubMed ID: 3062826
    [No Abstract]   [Full Text] [Related]  

  • 36. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dusodril in the ambulatory care of inner ear disorders].
    Hahn A
    Cesk Otolaryngol; 1989 Sep; 38(5):310-3. PubMed ID: 2582514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naftidrofuryl after acute stroke: a review and a hypothesis.
    Steiner TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S58-61. PubMed ID: 1369721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An experimental model of cerebral ischemia induced by microspheres in the rat. Effect of 2 Ginkgo biloba extracts and of naftidrofuryl].
    Larsen RG; Dupeyron JP; Boulu RG
    Therapie; 1978; 33(5):651-60. PubMed ID: 741425
    [No Abstract]   [Full Text] [Related]  

  • 40. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
    Grossmann W; Standl A; May U
    Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.